Intuit shares fell 9% after hours after the company issued weaker-than-expected full-year guidance. For fiscal 2027, Intuit projected EPS of $22.88-$23.12, below Wall Street’s $27.30 expectation, and revenue of $23.3 billion-$23.5 billion, trailing the $23.74 billion consensus. The outlook reflected slower-than-expected TurboTax growth and ongoing platform restructuring. Semtech gained 3% after reporting adjusted EPS of $0.71 on revenue of $341.9 million and issuing above-consensus third-quarter guidance for revenue of $405 million-$415 million and EPS of $1.02-$1.08, helped by 64% growth in AI data center networking. Spyre Therapeutics plunged 16% after its Phase 2 SKYWAY trial for SPY072, a TL1A inhibitor, failed to meet the company’s internal efficacy threshold for advancing as a monotherapy in rheumatoid arthritis. Zoom fell 3.5% despite a modest second-quarter beat and raised outlook, with EPS of $1.55, revenue of $1.28 billion and fiscal 2027 revenue guidance of $5.09 billion-$5.10 billion. Profit-taking and normalized growth in its core online segment weighed on the stock. nCino dropped 10% after reporting adjusted EPS of $0.05 on $161 million in revenue, while its third-quarter revenue outlook of $161.25 million-$163.25 million barely matched expectations and raised concerns about longer sales cycles among regional banking clients.